Trial intelligence / Profile preview

Safety of Synflorix co-administered with Infanrix hexa in Vietnamese infants

NCT01153841Phase 3Completed

Sponsor
GSK
Start
Feb 2011
Primary completion
Jul 2011
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Feb 2011; status: completed.

02

Drugs

10-valent pneumococcal conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT01153841.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01153841.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call